Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & Administrative
Others
Ratios

Odyssey Health (ODYY) Shares Outstanding (Weighted Average) (2016 - 2021)

Odyssey Health has reported Shares Outstanding (Weighted Average) over the past 8 years, most recently at $3.6 million for Q2 2021.

  • Quarterly results put Shares Outstanding (Weighted Average) at $3.6 million for Q2 2021, down 95.81% from a year ago — trailing twelve months through Apr 2021 was $3.6 million (down 95.81% YoY), and the annual figure for FY2020 was $644500.0, down 99.08%.
  • Shares Outstanding (Weighted Average) for Q2 2021 was $3.6 million at Odyssey Health, up from $1.1 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for ODYY hit a ceiling of $119.8 million in Q2 2018 and a floor of $644500.0 in Q3 2020.
  • Median Shares Outstanding (Weighted Average) over the past 5 years was $87.2 million (2020), compared with a mean of $74.6 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 313.85% in 2018 and later tumbled 99.08% in 2020.
  • Odyssey Health's Shares Outstanding (Weighted Average) stood at $14.8 million in 2017, then skyrocketed by 313.85% to $61.4 million in 2018, then surged by 41.65% to $87.0 million in 2019, then rose by 3.78% to $90.3 million in 2020, then tumbled by 95.96% to $3.6 million in 2021.
  • The last three reported values for Shares Outstanding (Weighted Average) were $3.6 million (Q2 2021), $1.1 million (Q1 2021), and $90.3 million (Q4 2020) per Business Quant data.